AR
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ·Healthcare·Biotechnology
$11.02
+2.37%
Mkt Cap $231.11M
Analyst Ratings
Buy
7
Hold
0
Sell
0
Price Target (4 analysts)
$37.50
Range $35.00 – $40.00
Implied Upside
+240.3%
Consensus $37.50 vs current $11.02